← Back to all trials
Recruiting
NCT05735236
Comparison of Methods in Post Operative Knee Arthroscopy Rehabilitation
Conditions: Muscle Weakness, Muscle Atrophy
Sex: All
Ages: 16 Years – 60 Years
Phase: NA
Enrollment: 78
Sponsor: University of Colorado, Denver
Location: United States
Summary
The aim of this study is to investigate the efficacy of blood flow restriction (BFR) therapy in post operative rehabilitation following knee arthroscopy.
Eligibility Criteria
Inclusion Criteria:Patients with ACL reconstruction with quadriceps, hamstring, bone-patellar-bone or allograft graft, with/without meniscectomies.
Patients must also have access to a smartphone device in order to utilize the SAGA BFR application for use.
The application is free to use.Exclusion Criteria:Bilateral knee surgeries to be performed within 12 weeks of each other, meniscus repairs, chondral lesion repair/transplants, ACL revisions that utilize contralateral autografts, MCL repairs, and the following BFR contraindications: deep vein thrombosis (DVT), pulmonary embolism, hemorrhagic/thrombolytic stroke, clotting disorders, hemophilia or taking blood thinners, pregnant or up to 6 months postpartum, untreated hypertension, untreated hypotension, rhabdomyolysis or recent traumatic injury, does not understand English, and the following BFR contraindications:Contraindications for BFRDeep Vein Thrombosis (DVT)Pulmonary EmbolismHemorrhagic/Thrombolytic StrokeClotting DisordersHemophilia or taking blood thinnersPregnant or up to 6 months post-partumUntreated HypertensionUntreated HypotensionRhabdomyolysis or recent traumatic injuryExclusion criteria will be evaluated via the medical record as well as by the expert opinion of the physician.If at any point in the study a subject develops one of the above contraindications, they will be removed from the study.If a subject becomes pregnant while participating in the intervention portion of the study, they will be removed.
Source: ClinicalTrials.gov (NCT05735236). StuddyBuddy aggregates publicly available trial information.